***There is no registration process for this event. A BLUE ENTER WEBINAR button will appear on this Landing Page 30 minutes prior to the event. You can click on the button at that time, and it will take you into the Webinar Waiting Room anonymously. ***
Erectile dysfunction (ED) affects more than 30 million men in the U.S. It is especially common in men with prostate surgery, diabetes, high blood pressure and obesity. However, it is now possible to treat almost all men with ED! ED undermines a man’s sexual confidence – but successful treatment can help restore it! Many ED treatments are covered by most insurance and prescription plans. Attend a FREE Men’s Health Webinar sponsored by Dr. Holden with Genesis Urology and Coloplast Corp. to educate men and their partners about approved ED treatment options. Your attendance will be confidential.
***Please use Chrome, Safari, or Firefox as your web browser for best results.***
Webinar Agenda:
  • Hard Facts about Erectile Dysfunction
  • Erectile Dysfunction Treatment Options
  • Patient Educator Video or Discussion
  • Q&A

Details About the Webinar

About the Speakers

1589899398-40aaa8c6785e363f Coloplast

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs.

1625009415-0ecd44742d945ca6 Marc Holden, MD

Dr. Marc Holden joined Genesis Healthcare in August of 2019. He received his medical degree from Columbia University College of Physicians & Surgeons and has been in practice more than 5 years.

Medical Education
Columbia University College of Physicians & Surgeons, MD, 2012
Residencies
University of California, San Diego, Urology, 2018
University of California, San Diego, General Surgery, 2013
Fellowships
Royal Australasian College of Surgeons, Urology, 2019

Registration is full. If you have already registered, please log in or use the link from your registration confirmation email.